Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

AstraZeneca PLC ADR (AZNN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,350.00 +48.29    +3.71%
05/12 - Closed. Currency in MXN ( Disclaimer )
  • Volume: 41
  • Bid/Ask: 1,290.00 / 1,350.00
  • Day's Range: 1,350.00 - 1,350.00
Type:  Equity
Market:  Mexico
ISIN:  US0463531089 
S/N:  046353108
AstraZeneca ADR 1,350.00 +48.29 +3.71%

Astrazeneca PLC DRC Company Profile

 
Read the Astrazeneca company profile to learn more about the business and the management team. View employee data, company address and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

83100

Equity Type

DRC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company’s marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Top Executives

Name Age Since Title
Euan A. Ashley 49 2020 Independent Non-Executive Director
Diana Layfield 50 2020 Independent Non-Executive Director
Leif Johansson 70 2012 Independent Non-Executive Chairman
Pascal Soriot 62 2012 CEO & Executive Director
Deborah DiSanzo Eldracher 61 2017 Independent Non-Executive Director
Shu Kam Mok 60 2019 Independent Non-Executive Director
Sherilyn S. D. McCoy 62 2017 Independent Non-Executive Director
Philip Arthur John Broadley 60 2017 Senior Independent Non-Executive Director
Katarina Ageborg - 2011 EVP of Sustainability, Chief Compliance Officer & Member of External Sustainability Advisory Board
Pam P. Cheng 50 2015 EVP of Operations & Information Technology and Member of External Sustainability Advisory Board
Polly Courtice 69 - Member of External Sustainability Advisory Board
Rain Henderson - - Member of External Sustainability Advisory Board
Pankaj Bhatia - - Member of External Sustainability Advisory Board
Louise Nicholls - - Member of External Sustainability Advisory Board
Andreas Rummelt 66 2021 Independent Non-Executive Director
Aradhana Sarin 47 2021 CFO & Executive Director
Menelas Pangalos - 2013 EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board
Jeffrey Pott - 2009 Chief Human Resources Officer, General Counsel & Member of External Sustainability Advisory Board
Michel Demare 66 2019 Independent Non-Executive Director
Marcus Wallenberg 66 1999 Non-Executive Director
Nazneen Rahman 54 2017 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about Astrazeneca PLC DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai May 09, 2021 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks you AstraZ. Bullish. management services.
Woon soo Lee
Woon soo Lee May 01, 2021 18:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
54 to 64 bullish sentiments again volatility trading
Poh Meng Kong
Poh Meng Kong Feb 25, 2021 22:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$68 in 1 month
Nelson T Machin
Nelson T Machin Feb 01, 2021 15:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you this will grow as EU has approved their Covid vaccine?
Frans Caruana
Frans Caruana Jan 25, 2021 20:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will reach 100 in 6 months time
Arek Rusak
Arek Rusak Dec 24, 2020 13:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think the vaccine is nothing next to the antibody coctail, known as AZD7442 that Astra is working on at the momenthttps://www.reuters.com/article/health-coronavirus-astrazeneca-antibody-idUSKBN28100E
bojidar zarev
bojidar zarev Dec 14, 2020 18:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good buy in the long term.
Andre Low
Andre Low Dec 12, 2020 13:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.wsj.com/articles/astrazeneca-agrees-to-buy-alexion-for-39-billion-11607778687?redirect=amp#click=https://t.co/EeYlRyEn3g
Nabeel Qabane
Nabeel Qabane Nov 30, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I expect it to reach $ 100 next month
Sandeep Agarwal
Sandeep Agarwal Oct 12, 2020 17:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
for super rich returns
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email